Moonwalk Biosciences
South San Francisco, United States · Founded 2023 · $28.5M raised
- Headquarters
- South San Francisco, California
- Employees
- 11–50
- Founded
- 2023
- Business Model
- B2B
- Website
- moonwalk.bio
- Total Funding
- $28.5M
- Last Round
- $28.5M SeedJan 2024
- Rounds
- 1
About
Develops precision epigenetic medicines targeting adipose biology and cardiometabolic disease using AI-driven epigenetic profiling and engineering.
Summary
Moonwalk Biosciences is a Biotech company based in South San Francisco, United States, founded in 2023. It has raised $28.5M in total across 1 round, most recently a $28.5M Seed round in Jan 2024. Investors include Alpha Wave Ventures, ARCH Venture Partners and Future Ventures.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2024
Investors
Similar Companies
Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...